Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Drugs
- Cancer
- Vaccine
- Biotechnology
- Delivery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 345331
License Grant
Licensor hereby grants to Licensee an exclusive, royalty-bearing right and license, in the Field in the Territory, including the right to grant sublicenses, to make, have made, use, develop, commercialize, offer for sale, have sold, and import Licensed Products.
License Property
License IP shall mean the Antigen Specific MRNA Cellular Cancer Vaccines.
Field of Use
Field shall mean therapeutic uses related to treatment in humans of pancreatic cancer.
IPSCIO Record ID: 27764
License Grant
Licensor grants to Licensee an exclusive, royalty-bearing right and license, in the Field in the Territory, including the right to grant sublicenses, under the Licensed Technology, to Develop, make, have made, use, Commercialize, offer for sale, have sold, and import Licensed Products. Field shall mean the use of Licensed Technology in the veterinary Non Human Field for therapeutic purposes.
License Property
The Licensor is a biotechnology company, focused on the development of regenerative medical applications in the United States, including provisional Patent Antigen Specific mRNA Cellular Cancer Vaccines, United States, 62165116, Provisional, 05/21/2015.
Field of Use
Licensee desires to obtain from Licensor an exclusive right and License for the development and commercialization of the License IP for non-human veterinary therapeutic use. Licensee is developing products treating blood disorders using small molecules based on nuclear receptor NR2F6.
IPSCIO Record ID: 256328
License Grant
This amendment revises the listed patents. Per the restated agreement, Licensor grants and agrees to grant to Licensee, upon the terms and conditions set forth in this Agreement, the exclusive rights under the Licensed Intellectual Property to make, have made, use and sell Licensed Products and Licensed Processes throughout the world and otherwise to exploit the Licensed Intellectual Property commercially throughout the world.
License Property
With this amendment, the patents are expanded and include Whole Recombinant Yeast Vaccine Activates Dendritic Cells and Elicits Protective Cell-Mediated Immunity, and, Yeast Dendritic Cell Vaccines and Uses Thereof, and, Yeast-Antigen Compositions And Methods Of Making The Same.
Field of Use
Per the restated agreement, the field of use is research and investigation for cancer therapies.
IPSCIO Record ID: 279375
License Grant
The license granted by Licensor to Licensee shall be an exclusive license as to the agreed upon Field of Use, with a right to grant sublicenses, during the Term, to use, develop, make, have made, practice, import, carry out, manufacture, have manufactured, offer for sale, sell, offer for sale and/or have sold Products in the Field of Use in the Territory.
License Property
Products shall consist of any substance, device, apparatus or method covered in whole or in part by a Valid Claim useful to the diagnosis or treatment of disease or disorders utilizing a dendritic cell based vaccine for brain tumors and other cancers.
Field of Use
Field of Use is certain provisional patents and other proprietary intellectual property, relating to the work of Dr. John Yu with cellular therapies or diagnostics utilizing cellular therapies, including dendritic cell based vaccines for brain tumors and other cancers. License is for a cancer vaccine therapy.
IPSCIO Record ID: 301043
License Grant
Licensor grants the exclusive license, with the right to grant sublicenses, under and to the Patent Rights during the term of this Agreement to conduct research in the Field of Use and to make, have made, use, import , offer for sale, sell and/or have sold Products in the Field of Use in the Territory.
License Property
The patent is titled Use of Toll-like receptor Ligands as adjuvants to vaccination therapy for brain tumors.
Field of Use
The Field of Use shall mean the therapeutic treatment thereof in patients suffering from cancer, including glioblastoma.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
